Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BINIMETINIB for Bladder cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where BINIMETINIB was used for Bladder cancer.

Most Reported Side Effects for BINIMETINIB

Side Effect Reports % Deaths Hosp.
Off label use 902 13.1% 150 179
Death 719 10.4% 710 47
Nausea 657 9.5% 33 181
Fatigue 562 8.1% 36 144
Diarrhoea 521 7.5% 31 212
Product use in unapproved indication 508 7.4% 86 64
Pyrexia 490 7.1% 30 215
Neoplasm progression 387 5.6% 122 88
Vomiting 375 5.4% 20 145
Rash 360 5.2% 19 80
Serous retinal detachment 299 4.3% 13 56
Arthralgia 206 3.0% 6 38
Malaise 205 3.0% 20 67
Decreased appetite 198 2.9% 25 85
Vision blurred 197 2.9% 5 44

Other Indications for BINIMETINIB

Malignant melanoma (2,613) Metastatic malignant melanoma (841) Colon cancer (715) Product used for unknown indication (235) Metastasis (172) Neoplasm malignant (171) Thyroid cancer (113) Non-small cell lung cancer (95) Colorectal cancer metastatic (91) Colorectal cancer (74)

Other Drugs Used for Bladder cancer

BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,279) PEMBROLIZUMAB (869) GEMCITABINE (841) CISPLATIN (780) ENFORTUMAB VEDOTIN-EJFV (530) NIVOLUMAB (512) ATEZOLIZUMAB (487) CARBOPLATIN (332) BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (326) GEMCITABINE\GEMCITABINE (240)

Related Pages

BINIMETINIB Full Profile All Bladder cancer Drugs BINIMETINIB Demographics BINIMETINIB Timeline